Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(75%)

Phase Distribution

Ph phase_4
2
50%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(3)
Other(1)

Detailed Status

Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 42 (50.0%)

Trials by Status

terminated375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_4

The Effects of Enoximone in Acute Exacerbation COPD

NCT04420455
terminatedphase_3

ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

NCT00051285
terminatedphase_3

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

NCT00077948
unknownphase_4

Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis

NCT00484133

Clinical Trials (4)

Showing 4 of 4 trials
NCT04420455Phase 4

The Effects of Enoximone in Acute Exacerbation COPD

Terminated
NCT00051285Phase 3

ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

Terminated
NCT00077948Phase 3

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

Terminated
NCT00484133Phase 4

Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4